These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12591356)

  • 1. Nuclear factor kappa B activation in glomeruli of posttransplant IgA nephropathy using southwestern histochemistry.
    Hong SW; Jeong HJ; Kim YS; Kim SI; Choi KH; Lee HY; Han DS; Park K
    Transplant Proc; 2003 Feb; 35(1):179-80. PubMed ID: 12591356
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
    Ashizawa M; Miyazaki M; Abe K; Furusu A; Isomoto H; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Kidney Dis; 2003 Jul; 42(1):76-86. PubMed ID: 12830459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic evaluation of IgA nephropathy in renal transplant recipients.
    Toki K; Oka K; Kyo M; Yazawa K; Tanaka T; Wang J; Permpongkosol S; Takahara S; Kokado Y; Moriyama T; Imai E; Okuyama A
    Transplant Proc; 2001; 33(1-2):1249-53. PubMed ID: 11267280
    [No Abstract]   [Full Text] [Related]  

  • 4. Vessel sclerosis and progression in IgA nephropathy.
    Feiner HD; Galvin S; Neelakantappa K; Baldwin D; Gallo GR
    Contrib Nephrol; 1984; 40():222-7. PubMed ID: 6499453
    [No Abstract]   [Full Text] [Related]  

  • 5. Histology and immunohistology of IgA nephropathy.
    Haas M
    J Nephrol; 2005; 18(6):676-80. PubMed ID: 16358224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy.
    Chao TK; Rifai A; Ka SM; Yang SM; Shui HA; Lin YF; Sytwu HK; Lee WH; Kung JT; Chen A
    Kidney Int; 2006 Jul; 70(2):283-97. PubMed ID: 16738538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin A nephropathy in renal transplant recipients.
    Koselj M; Rott T
    Transplant Proc; 1992 Dec; 24(6):2762-4. PubMed ID: 1465932
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenetic aspects of IgA nephropathy.
    Rantala I; Mustonen J; Hurme M; Syrjänen J; Helin H
    Nephron; 2001 Jul; 88(3):193-8. PubMed ID: 11423748
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of IgA nephropathy after ABO-incompatible living kidney transplantation.
    Takeuchi O; Oikawa T; Usami T; Koyama K; Takeda A; Uchida K; Morozumi K
    Clin Transplant; 1999; 13 Suppl 1():38-42. PubMed ID: 10751055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.
    Suzuki S; Kobayashi H; Sato H; Arakawa M
    Clin Nephrol; 1990 Feb; 33(2):66-71. PubMed ID: 2107051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent studies on S-protein in glomeruli from patients with IgA nephropathy.
    Tomino Y; Yagame M; Eguchi K; Nomoto Y; Sakai H
    Am J Pathol; 1987 Nov; 129(2):402-6. PubMed ID: 3314533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular deposition of complex-forming glycoprotein heterogenous in charge (protein HC) in IgA nephropathy.
    Imai H; Wakui H; Ishino T; Komatsuda A; Nakamoto Y; Miura AB; Kobayashi R
    Clin Nephrol; 1992 Apr; 37(4):169-76. PubMed ID: 1374693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA nephropathy in Japan.
    Glassock RJ; Kurokawa K; Yoshida M; Sakai O; Okada M; Shigematsu H; Ohno J; Sakai H
    Am J Nephrol; 1985; 5(2):127-37. PubMed ID: 3993701
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation of paramesangial deposits and glomerular sclerosis and/or hyalinosis in patients with IgA nephropathy.
    Tomino Y; Sakai H; Basolo B; Aarons I; Clarkson AR
    Tokai J Exp Clin Med; 1986 Oct; 11(4):235-9. PubMed ID: 2441490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.
    Lin TJ; Yang SS; Hua KF; Tsai YL; Lin SH; Ka SM
    Free Radic Biol Med; 2016 Oct; 99():214-224. PubMed ID: 27519267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA nephropathy in chronic liver disease.
    Nochy D; Druet P; Bariety J
    Contrib Nephrol; 1984; 40():268-75. PubMed ID: 6389002
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic glomerulosclerosis with IgA deposition. Report of three cases.
    Suga T; Endoh M; Miura M; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1983 Nov; 8(4):317-24. PubMed ID: 6388033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of IgA deposits/disease in grafts. An Australian Registry Survey 1980-1990.
    Hartung R; Livingston B; Excell L; Disney A; Woodroffe AJ
    Contrib Nephrol; 1995; 111():13-6; discussion 16-7. PubMed ID: 7758333
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between glomerular injuries and the existence of cytokines in glomeruli of patients with IgA nephropathy.
    Tsushima Y; Tomino Y; Shimizu M; Kuramoto T; Koide H; Eguchi K; Sakai H
    Nephron; 1993; 63(1):110. PubMed ID: 8446237
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapidly progressive glomerulonephritis in a renal transplant with recurrent IgA nephropathy.
    Park SB; Joo I; Park KA; Cho WH; Park CH; Kim SP; Park KK; Kim HC
    Transplant Proc; 1996 Jun; 28(3):1529-30. PubMed ID: 8658772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.